We demonstrated that ventromedial hypothalamus (VMH) lesions facilitate DNA synthesis, which reflects cell proliferation in abdominal organs, including the liver, pancreas, stomach, small intestine and large intestine, all of which are amply innervated by the vagal nerve. OBJECTIVE: To investigate which area DNA synthesis facilitates and what factors contribute to cell proliferation in the small intestine in VMH-lesioned rats. DESIGN: At 7 days after VMH lesions or sham operations, a segment of rat jejunum was taken for histological examination. A part of the jejunum was also removed from VMH-lesioned and sham-operated rats after 3 days and examined for 5-bromo-2 0 -deoxyuridine (BrdU) incorporation. At 6, 12 and 24 h after VMH lesions, the proximal intestine was removed from individual rats, from the pylorus to the mid-jejunum. Total RNA was extracted from these tissues of each rat, and the levels of epidermal growth factor (EGF) and transforming growth factor (TGF)-a mRNA were determined using reverse-transcription polymerase chain reaction. Cyclooxygenase (COX)-1 and -2 mRNA levels were determined using Northern blotting. RESULTS: Jejunal villi in VMH-lesioned rats were markedly enlarged compared to those of sham-operated rats and jejunal crypts in VMH-lesioned rats more markedly incorporated BrdU. Northern blot analysis revealed an increase in COX-1 mRNA after 6, 12 and 24 h in the jejunum of VMH-lesioned rats. COX-2 mRNA was decreased 6 and 12 h after VMH lesioning; however, it was significantly increased 24 h after VMH lesions in comparison to sham-operated rats. The levels of EGF and TGF-a mRNA were unchanged in VMH lesioned rats. CONCLUSION: VMH lesions induced enlargement of jejunal villi and increased the gene expression of COX-1 in the small intestine. Prostaglandins, probably E 2 , induced by COX-1 may be one candidate factor responsible for the cell proliferation of the small intestinal epithelium in these rats.
Introduction
The intestinal epithelium is known to be one of the most rapidly and continuously regenerating tissues in the body.
Intestinal epithelial cells are ultimately derived from multipotent stem cells located near the base of each intestinal crypt. In the small intestine, these crypt stem cells differentiate into rapidly replicating transit cells and rarely reverse into daughter stem cells. Transit cells subsequently differentiate into the mature epithelial cells and the composition of the intestinal epithelium is strictly maintained by fine local control mechanisms regulating cell proliferation and apoptosis. [1] [2] [3] [4] Bilateral ventromedial hypothalamus (VMH) lesions can produce obesity in animals. Autonomic derangements have been advanced for the cause of obesity. 5 These rats are known to have hyperphagia, 6 hyperinsulinemia, 7, 8 hyperleptinemia 9, 10 and hyperactivity of the vagal nerve. 11, 12 We previously reported that VMH lesioning increased abdominal organ weights and DNA content in the liver, pancreas, stomach and intestine. [13] [14] [15] [16] We further demonstrated that DNA synthesis was increased by showing that 3 H-thymidine incorporation in the stomach, small intestine and large intestine was significantly increased, peaked after 3 days and then returned to baseline levels 7 days after VMH lesioning. 16 Further, we found that the enhanced DNA synthesis in the small intestine depended on the hyperactivity of the vagal nerve by showing that 3 H-thymidine incorporation reversed by subdiaphragmatic vagotomy but not on hyperphagia or hyperinsulinemia. 16 There is a possibility that the increased DNA synthesis in the gastrointestinal tract of VMH-lesioned animals was facilitated by some factors locally released by the firing of the vagus nerve. However, the location of tissue with increased DNA synthesis and the identification of such factors capable of inducing cell proliferation in VMH-lesioned animals remained unknown. To determine the location and possible factors involved with an increase in DNA synthesis, histological examination of hematoxylin-eosin-stained sections from segments of the small intestine and immunohistochemical examination of 5-bromo-2 0 -deoxyuridine (BrdU) incorporation were performed to evaluate possible proliferation of intestinal cells. Levels of epidermal growth factor (EGF) and transforming growth factor (TGF)-a mRNA were examined, as these two cytokines are known factors involved in intestinal cell proliferation. [17] [18] [19] Moreover, we evaluated mRNA levels of cyclooxygenase (COX), a rate-limiting enzyme for prostaglandin (PG) synthesis, since PGs are also known to induce cell hyperplasia in the small intestine.
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Materials and methods
Animals and experimental procedures
Female Sprague-Dawley rats weighing around 280 g (Japan SLC Inc., Hamamatsu, Japan) were used in all experiments. They were maintained in individual cages on a condition of rotating 12 h light-dark cycle with an ambient temperature of 24711C, and were allowed free access to standard rat chow (Oriental Food Co., Tokyo, Japan) and water. The animals were anesthetized by intraperitoneal injection of pentobarbital sodium (50 mg/kg, Dainippon Pharmaceutical, Osaka, Japan) at 6, 12 or 24 h after VMH lesions or sham operations. After the operation, animals were allowed free access to food and water. Blood was taken from the abdominal aorta, and then the proximal intestines were removed from the pylorus to the mid-jejunum, opened, washed with saline and snap frozen in liquid nitrogen. The tissues were stored at À801C for subsequent RNA extraction for determination of mRNA levels. Food intake was measured during first 24 h after the operation. The blood samples were centrifuged at 41C and plasma stored at -801C until assayed. A portion of tissue samples taken 7 days after VMH lesioning was utilized for histological examination. A segment of the jejunum was also taken 3 and 7 days after VMH lesioning for examining for BrdU incorporation (n ¼ 6) and histological staining, respectively.
Bilateral VMH lesions
The rats were anesthetized by inhalation of Isoflurane (Forane; Dinabot, Osaka, Japan), and electrolytic bilateral VMH lesions were performed by the method previously described. 8, 10 For sham operations, the same surgical procedures were performed without electric current flow. At the end of the experiments, the area and extent of the hypothalamic lesions in all animals was confirmed histologically.
Bromodeoxyuridine labeling
For BrdU incorporation examination, rats were injected intraperitoneally with BrdU (Wako, Osaka, Japan) at a dose of 30 mg/kg in body weight 2 h before being killed 3 days after VMH lesioning. Rats were anaesthetized by sodium pentobarbital and then killed by decapitation. The jejunum was removed and fixed with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, for 16 h. The tissues were dehydrated through a graded ethanol series, embedded in paraffin, and cut in cross-sections at 8 mm thickness. Deparaffinized sections were incubated with a mouse monoclonal anti-BrdU (Amersham, Arlington Heights, IL, USA). Bound anti-BrdU was subsequently visualized with ABC method (Vector stain ABC kit, Vector Laboratories, Burlingame, CA, USA), using diaminobenzidine as the chromogen. The number of BrdU-incorporated cells per crypt was counted under a light microscope (10 sections per animal, n ¼ 5).
Histological examinations
The jejunum was removed from sham-operated and VMHlesioned animals 7 days after the operations under pentobarbital sodium (50 mg/kg, Dainippon Pharmaceutical) anesthesia and the animals euthanased. The tissue specimens were placed in 10% buffered formalin for 1 week and embedded in paraffin. Examinations were made on hematoxylin-eosin-stained sections (n ¼ 5).
Subcloning of COX-1 or COX-2 cDNA fragment using RT-PCR COX-1 cDNA or COX-2 cDNA was synthesized from total RNA in a rat jejunum. Total RNA from the rat jejunum was reverse-transcribed using an oligo d(T) [12] [13] [14] [15] [16] [17] [18] 0 , Gene Bank accession S67722 and AmpliTaq Gold (Perkin-Elmer, Foster, CA, USA). Either the resulting 1631 bp fragment for COX-1 or 1150 bp fragment for COX-2 was cloned into TA-cloning vector, pGEM-T Easy (Promega, Madison, WI, USA). The nucleotide sequence of the COX-1 or COX-2 insert in pGEM-T Easy was confirmed by automatic sequencing (Shimadzu, Kyoto, Japan). The plasmid inserted COX-1 or COX-2 was digested with EcoRI and then COX-1 or COX-2 DNA fragments generated for probe use.
RNA preparation
Total RNA was isolated from the jejunum of each rat using TRIzol reagent (Life Technologies, Inc., Rockville, MD, USA) according to the manufacturer's protocol. RNA was quantified spectrophotometrically and confirmed by ethidium bromide staining of 18S and 28S ribosomal RNA after electrophoresis on a 1% agarose/formaldehyde gel.
RNA quantification by Northern blot analysis
A portion of total RNA was loaded at 15 mg per lane on a 1% agarose/formaldehyde gel and transferred onto a nylon membrane (Hybond N+, Amersham, Arlington Heights, IL, USA). RNA blots were stained with methylene blue to locate 28S and 18S rRNAs and to ascertain the amount of loaded RNAs after transfer. Membranes were then hybridized with [a-
32 P]dCTP-labeled cDNA probe (megaprime DNA labeling system, Amersham) for COX-1 and COX-2 for 16 h. Following washing, signals were quantified by the Fujix BAS2000 Bio-imaging Analyzer (Fuji Photo Film Co. Ltd, Tokyo, Japan) and then by X-ray films (Fuji Photo Film Co. Ltd) placed at À801C using an intensifying screen.
RNA quantification by RT-PCR Each total RNA was used for the determination of the gene expression levels of EGF, TGF-a and glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) (as an internal control) by RT-PCR. Total RNA (4 mg) was converted into cDNA using oligo d(T) [12] [13] [14] [15] [16] [17] [18] primer (Life Technologies Inc.) and Moloney murine leukemia virus reverse transcriptase (Life Technologies Inc.) in an RT reaction mixture (20 ml). PCR was performed using 0.8 ml of the RT reaction mixture, 0.5 mM of each primer (forward and reverse primers) and AmpliTaq Gold DNA polymerase (Perkin-Elmer) in a total reaction volume (25 ml). As primers for rat EGF, TGF-a and GAPDH transcripts, we used 5 0 -GACTATAACGGTGGCTCCATCC-3 
Biochemical measurements
Plasma glucose levels were determined by the glucose oxidase method (Glucose B-test, Wako Pure Pharmaceutical Industries Ltd, Osaka, Japan). Plasma immunoreactive insulin concentrations were determined by a radioimmunoassay kit (Cat#RI-13K, Linco Research Inc, St Charles, MO, USA).
Statistical analysis
All data were expressed as the mean7s.e. (s.e.m.). Statistical analyses were performed with the StatView J-4.5 for the Macintosh system. The statistical significance of difference was assessed by unpaired Student's t-test. Table 1 shows the characteristic features of rats with and without VMH lesions 24 h after the operations. Food intake in VMH-lesioned rats was significantly elevated. No significant difference was observed in plasma glucose levels between VMH-lesioned and sham-operated rats. Plasma insulin levels in VMH-lesioned rats were higher than in sham-operated rats. Figure 1 illustrates histologically the jejunal villi of VMHlesioned rats 7 days after the lesioning. The height of the jejunal villi in VMH-lesioned rats was markedly enlarged (more than two times) when compared with those of shamoperated rats.
Results
The site of BrdU incorporation was in crypt areas of the jejunum in both VMH-lesioned and sham-operated rats (Figure 2 ). BrdU incorporation in the crypt area of jejunums in rats 3 days after the operations was significantly higher in VMH-lesioned than in sham-operated animals (Po0.0001). 
VMH lesions in jejunal hyperplasia
H Kageyama et al Figure 3 compares the levels of gene expression of COX-1 and COX-2 in isolated jejunums 24 h after VMH lesions. The expression of jejunal COX-1 mRNA was markedly increased (by 213%) in VMH-lesioned rats. The level of two identified isoforms of COX-2, that is, COX-2L and COX-2S, was also significantly increased (by 147 and 131%, respectively) in VMH-lesioned animals, although less than that observed for COX-1. Figure 4 indicates the time course of the altered expression of COX-1 and COX-2 mRNAs in the jejunum in rats 6, 12 and 24 h after VMH lesioning. The expression of COX-1 mRNA in the jejunum of rats 6 and 12 h after VMH lesions was significantly increased (by 170 and 157%, respectively). However, levels of both COX-2 mRNAs were decreased when compared with those of corresponding sham-operated rats. The level of COX-2L mRNA in the jejunum of rats 6 h after VMH lesioning was decreased by 55%, and by 75% at 12 h after VMH lesioning. The level of COX-2S in rats 6 h after VMH lesioning was decreased by 36%, and by 62% at 12 h after VMH lesioning.
The levels of EGF and TGF-a mRNA were not detectable by Northern blotting. However, expression patterns of EGF and TGF-a mRNA when examined by RT-PCR did not differ between VMH-lesioned and sham-operated rats in the jejunum 24 h after operations ( Figure 5 ).
Discussion
In this study, we found increased gene expressions of COXs (a rate-limiting enzyme of PG biosynthesis): COX-1 continued to increase until the end of 24 h after VMH lesioning, and COX-2 initially decreased and increased at the end of the experiment. We further found that BrdU incorporation specifically limited to jejunal crypt 3 days after VMH lesioning and height of jejunal villi increased 7 days after the lesioning. These imply that the increased COX expression induced PG production, which led to cell proliferation in the jejunum in these rats.
There are two possibilities for the elevated height of these intestinal villi, that is, cell proliferation and/or cell hypertrophy. The results of incorporation of BrdU in this study revealed that VMH lesions promoted DNA synthesis in the jejunal crypt but not in the mature, differentiated epithelial cells. Therefore, VMH lesions promoted cell hyperplasia in the epithelial generative cells located in the crypts, resulting in the enlarged height of the small intestinal villi in VMHlesioned rats.
Many growth factors exist in the gastrointestinal (GI) tract, of which EGF and TGF-a are considered to be particularly important. 18 Both peptides promote cell proliferation 17, 19 and stimulate cell migration. 22 Our previous results indicated that 3 H-thymidine incorporation increased immediately after VMH lesioning, peaked after 3 days and then returned to baseline levels at 7 days. 16 We presumed that the signal for the cell proliferation observed should be received by the abdominal organs before the peak (3 days) of 3 Hthymidine. To explore whether these peptides are involved in the cell proliferation induced by VMH lesions, we 
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H Kageyama et al examined the gene expressions of EGF and TGF-a in the jejunum of rats 24 h after VMH lesions. Both EGF and TGF-a mRNA were undetectable by Northern blotting. However, the results of RT-PCR revealed that the gene expressions of these peptides did not differ between VMH-lesioned and sham-operated rats, suggesting that EGF and TGF-a do not significantly contribute to the hyperplasia that occurs after VMH lesioning.
E series of PG are intimately involved in the healing process of nonsteroidal anti-inflammatory drug (NSAID)-induced gastroduodenal ulcer. NSAIDs treatment reduces the expression and activity of COXs, which results in the reduction of PGs. Thus, the reduction in PGE 2 might lead to the development of GI ulcers in which PGE 2 is considered as an important mediator of epithelial integrity and function in the GI tract. 23 In fact, natural PGE 2 and its analog showed abilities of enlargement in villous height. 24, 25 These results suggest that endogenous PGE 2 has the potential to induce intestinal cell hyperplasia, resulting in the elevation of villi height. COX is a rate-limiting enzyme for PG synthesis. There are two isomers, COX-1 and COX-2, with approximately 60% homology. 26 Furthermore, COX-2 mRNAs have two isoforms (COX-2L for long form, COX-2S for short form), which are produced by alternative polyadenylation. 27 It appears that two COXs are differently regulated and have different functions. COX-1 is constitutively expressed in many tissues including kidney, lung, stomach, duodenum, jejunum and colon. 28, 29 In contrast, COX-2 is undetectable in normal condition; however, it is rapidly expressed in response to several stimuli such as inflammation, growth factors and cytokines. [29] [30] [31] [32] [33] COX-1 activity is considered to be responsible for producing cytoprotective prostaglandins such as PGE 2 , which are critical to maintain integrity of gastric mucosa. 34, 35 COX-2 seems to be involved in manifestations of infectious and neoplasmatic diseases. [36] [37] [38] In this study, we found that COX-1 mRNA continuously and extensively increased during experimental period, while COX-2 mRNA initially decreased and transiently increased. The results suggest that the increased COX-1 has the primary role on hyperplasia of intestinal epithelium through PGE 2 production in VMH-lesioned rats. The reason as to why COX-2 mRNA initially decreased and transiently increased is unknown at present. Corticosterone release is very rapidly increased after VMH lesioning, 39 and this hormone attenuates COX-2 mRNA. 40 Thus, we may consider that COX-2 mRNA was downregulated by the increase in corticosterone in the initial period of experiment; however, pain 29 or inflammatory stimulus 41 may be involved in the transient increase in COX-2 mRNA in the later period. On the other hand, COX-1 mRNA was not affected by these factors since the increase in COX-1 mRNA was induced by VMH lesioning through vagus firing, which is the main cause of intestinal cell proliferation in these rats. 16 How does PGE 2 contribute to the cell hyperplasia in jejunal epithelium? Hyperplasia derives from an increase in DNA synthesis and/or cell survival prolongation. Administration of PGE 2 increased DNA synthesis and the number of crypt cells in the rat jejunum. 42, 43 The results are consistent with our previous report that found that 3 H-thimidine uptake was enhanced in GI organs. 16 On the other hand, cell kinetics studies indicated that the hyperplasia in the small intestine caused by PGE 2 was associated with a prolonged cell survival time. 25, 44 Taken together, jejunal hyperplasia was produced by both DNA synthesis and cell survival prolongation mediated through PGE 2 . VMH-lesioned animals show hyperactivity of the parasympathetic nerve and hypoactivity of the sympathetic 
H Kageyama et al nerve. 5 PGs are not stored in tissues, but are synthesized and released upon stimulation. 45 It is reported that PGs were released by stimulation of the parasympathetic nerve. 46 Thus, it is possible that the production of PGs is enhanced by increased COX-1 level through hyperactivation of the parasympathetic nerve and is over-released in VMH-lesioned rats, implying that increased COX-1 level might be also produced by hyperactivity of the vagus nerve in VMHlesioned rats. There is other possibility that the production of PGs is enhanced by increased COX-1 level mediated through some other growth factors, for example, interleukins or glucocorticoid. 47, 48 In conclusion, we demonstrated that VMH lesioning induced intestinal cell hyperplasia but not hypertrophy, resulting in the enlargement of villi height. We also demonstrated that the gene expression of COX-1 in the intestine was enhanced in VMH-lesioned rats. These suggest that PGs, probably PGE 2 , induced by elevation of COX-1 enzyme activities, contribute to cell proliferation through DNA synthesis and cell survival prolongation. 
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